A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia
Clinical trial NCT02816164 · COMPLETED
Trial details
- NCT number
- NCT02816164
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-02-01
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.